| Gregory P Tokarsky, MD | |
|
3500 Arendell St, Morehead City, NC 28557-2901 | |
| (330) 493-4443 | |
| (330) 493-8677 |
| Full Name | Gregory P Tokarsky |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 3500 Arendell St, Morehead City, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780626242 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 200600649 (North Carolina) | Primary |
| Entity Name | University Of Maryland Emergency Medicine Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144271743 PECOS PAC ID: 1951294941 Enrollment ID: O20040204000360 |
News Archive
A study in the Journal of Biological Chemistry identifies a new therapeutic approach to treat prostate cancer. Conducted at Cincinnati Children's Hospital Medical Center, the research shows that expression of the FoxM1 protein is essential for prostate cancer to develop in mouse models. The study appears in the journal's Aug. 2 edition.
Nearly 50,000 Americans are diagnosed each year with stage III or locally advanced NSCLC, for which surgery is usually not a viable treatment option. Optimizing nonsurgical treatment strategies for these patients is an ongoing research endeavor.
Using a common virus as a tool for investigating abnormal cell proliferation, a team led by scientists at Cold Spring Harbor Laboratory (CSHL) has succeeded in clarifying an intricate series of biochemical steps that shed light on a way that cancer can begin.
The protein alpha-synuclein is a well-known player in Parkinson's disease and other related neurological conditions, such as dementia with Lewy bodies. Its normal functions, however, have long remained unknown.
Biotest Pharmaceuticals Corporation, a leading developer of immunology biotherapeutic products, is pleased to announce that it has opened a new plasma collection center. The state-of-the-art, 15,000 square foot facility located at 113 Yopp Road, Jacksonville, North Carolina, is BPC's second plasma center in Jacksonville, and officially opened its doors for business on February 3, 2015.
› Verified 2 days ago
| Entity Name | Baltimore Washington Emergency Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215983853 PECOS PAC ID: 3577451103 Enrollment ID: O20040305001004 |
News Archive
A study in the Journal of Biological Chemistry identifies a new therapeutic approach to treat prostate cancer. Conducted at Cincinnati Children's Hospital Medical Center, the research shows that expression of the FoxM1 protein is essential for prostate cancer to develop in mouse models. The study appears in the journal's Aug. 2 edition.
Nearly 50,000 Americans are diagnosed each year with stage III or locally advanced NSCLC, for which surgery is usually not a viable treatment option. Optimizing nonsurgical treatment strategies for these patients is an ongoing research endeavor.
Using a common virus as a tool for investigating abnormal cell proliferation, a team led by scientists at Cold Spring Harbor Laboratory (CSHL) has succeeded in clarifying an intricate series of biochemical steps that shed light on a way that cancer can begin.
The protein alpha-synuclein is a well-known player in Parkinson's disease and other related neurological conditions, such as dementia with Lewy bodies. Its normal functions, however, have long remained unknown.
Biotest Pharmaceuticals Corporation, a leading developer of immunology biotherapeutic products, is pleased to announce that it has opened a new plasma collection center. The state-of-the-art, 15,000 square foot facility located at 113 Yopp Road, Jacksonville, North Carolina, is BPC's second plasma center in Jacksonville, and officially opened its doors for business on February 3, 2015.
› Verified 2 days ago
| Entity Name | Emergency Physicians Spps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760885958 PECOS PAC ID: 0648594036 Enrollment ID: O20150113000263 |
News Archive
A study in the Journal of Biological Chemistry identifies a new therapeutic approach to treat prostate cancer. Conducted at Cincinnati Children's Hospital Medical Center, the research shows that expression of the FoxM1 protein is essential for prostate cancer to develop in mouse models. The study appears in the journal's Aug. 2 edition.
Nearly 50,000 Americans are diagnosed each year with stage III or locally advanced NSCLC, for which surgery is usually not a viable treatment option. Optimizing nonsurgical treatment strategies for these patients is an ongoing research endeavor.
Using a common virus as a tool for investigating abnormal cell proliferation, a team led by scientists at Cold Spring Harbor Laboratory (CSHL) has succeeded in clarifying an intricate series of biochemical steps that shed light on a way that cancer can begin.
The protein alpha-synuclein is a well-known player in Parkinson's disease and other related neurological conditions, such as dementia with Lewy bodies. Its normal functions, however, have long remained unknown.
Biotest Pharmaceuticals Corporation, a leading developer of immunology biotherapeutic products, is pleased to announce that it has opened a new plasma collection center. The state-of-the-art, 15,000 square foot facility located at 113 Yopp Road, Jacksonville, North Carolina, is BPC's second plasma center in Jacksonville, and officially opened its doors for business on February 3, 2015.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory P Tokarsky, MD 4535 Dressler Rd Nw, Canton, OH 44718-2545 Ph: (330) 493-4443 | Gregory P Tokarsky, MD 3500 Arendell St, Morehead City, NC 28557-2901 Ph: (330) 493-4443 |
News Archive
A study in the Journal of Biological Chemistry identifies a new therapeutic approach to treat prostate cancer. Conducted at Cincinnati Children's Hospital Medical Center, the research shows that expression of the FoxM1 protein is essential for prostate cancer to develop in mouse models. The study appears in the journal's Aug. 2 edition.
Nearly 50,000 Americans are diagnosed each year with stage III or locally advanced NSCLC, for which surgery is usually not a viable treatment option. Optimizing nonsurgical treatment strategies for these patients is an ongoing research endeavor.
Using a common virus as a tool for investigating abnormal cell proliferation, a team led by scientists at Cold Spring Harbor Laboratory (CSHL) has succeeded in clarifying an intricate series of biochemical steps that shed light on a way that cancer can begin.
The protein alpha-synuclein is a well-known player in Parkinson's disease and other related neurological conditions, such as dementia with Lewy bodies. Its normal functions, however, have long remained unknown.
Biotest Pharmaceuticals Corporation, a leading developer of immunology biotherapeutic products, is pleased to announce that it has opened a new plasma collection center. The state-of-the-art, 15,000 square foot facility located at 113 Yopp Road, Jacksonville, North Carolina, is BPC's second plasma center in Jacksonville, and officially opened its doors for business on February 3, 2015.
› Verified 2 days ago
Austin W Burgess, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 Arendell St, Morehead City, NC 28557 Phone: 252-808-6589 Fax: 252-808-6947 | |
Dr. Douglas Holt, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 Arendell St, Carteret General Hospital, Morehead City, NC 28557 Phone: 252-808-6133 | |
Joseph C Dell'aria, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 Arendell St, Morehead City, NC 28557 Phone: 330-493-4443 Fax: 330-493-8677 | |
Dr. John R Duda, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3500 Arendell St, Morehead City, NC 28557 Phone: 330-493-4443 | |
Laura Beth Miller, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3500 Arendell St, Carteret General Hospital, Morehead City, NC 28557 Phone: 252-808-6000 |